Search Results for: Hypertension

A Randomized, Open-label, Parallel-controlled, Multicenter Phase III Clinical Study Evaluating TQB2930 Combined With Investigator’s Choice of Chemotherapy Versus Trastuzumab Combined With Investigator’s Choice of Chemotherapy in the Treatment of HER2-Positive Advanced Breast Cancer

A Randomized, Open-label, Parallel-controlled, Multicenter Phase III Clinical Study Evaluating TQB2930 Combined With Investigator’s Choice of Chemotherapy Versus Trastuzumab Combined With Investigator’s Choice of Chemotherapy in the Treatment of HER2-Positive Advanced Breast Cancer

Tuberculosis News
Publication date: Jun 24, 2025 TQB2930 is a HER2 bispecific antibody drug. This study aims to evaluate the efficacy and safety of TQB2930 combined with investigator’s choice of chemotherapy versus ... Read more